Log in to your Inderes Free account to see all free content on this page.

AlzeCure Pharma

1.47 SEK

+6.52%

Less than 1K followers

ALZCUR

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for AlzeCure Pharma

EV/EBIT

Median 2019-2021

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (SEK)3.537.805.123.712.791.092.00
Shares43.943.943.956.669.392.9114.9
Market cap154.8342.2224.7210.0193.1101.5229.8
Enterprise value-27.7229.7183.0----
EV/S-------
EV/EBITDA0.5neg.neg.----
EV/EBIT0.5neg.neg.----
P/Eneg.neg.neg.neg.neg.neg.neg.
P/B0.853.096.813.478.123.886.98
P/S-------
Dividend yield0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio97.5 %94.0 %72.2 %85.4 %74.3 %76.0 %55.8 %
Gearing ratio------7.8 %
Login required

This content is only available for logged in users